Market News

24/7 Wall Street News Agency

4 days ago•24/7 Wall Street

Stocks Medium Importance Neutral

CoreWeave is Off 20% Over 3 Months: A Prominent Tech Analyst Expects 65% Gains This Cycle

CoreWeave (NASDAQ:CRWV) currently trades at $91.90 against a consensus analyst target of $138.03.

Related Symbols 1

C CRWV CRWV

Source: 24/7 Wall Street

Visit Source

0 0 0

Comment

Seeking Alpha News Agency

4 days ago•Seeking Alpha

Stocks Medium Importance Neutral

AppLovin: A Dip We Were All Waiting For (Rating Upgrade)

AppLovin Corporation delivered a robust quarter with 52.4% revenue growth and an 83.8% adjusted EBITDA margin, yet shares sold off sharply on modest headline misses. APP's balance sheet is strong, with $3B cash, $3.5B debt, and a 29x interest coverage ratio, supporting continued self-funded growth. Opening AXON Ads to self-serve expands TAM, targeting $7B in first-year ad spend from new verticals beyond gaming, including fintech and CTV.

Related Symbols 1

A APP APP

Source: Seeking Alpha

Visit Source

0 0 0

Comment

Proactive Investors News Agency

4 days ago•Proactive Investors

Stocks Medium Importance Neutral

Nasdaq heading lower on earnings falls for AppLovin, Western Digital and SanDisk

Wall Street was predicted to see a mixed open on Thursday, as another batch of technology earnings undermines confidence and apparent progress towards an Iran deal raises fears of yet another false dawn. Dow Jones futures were up 57 points, or 0.1%, with the blue-chip index on course to build on the previous session's record close.

Related Symbols 1

N NDAQ NDAQ

Source: Proactive Investors

Visit Source

0 0 0

Comment

GlobeNewsWire News Agency

4 days ago•GlobeNewsWire

Stocks Medium Importance Neutral

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced that it will report financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. The Company will host a conference call and webcast at 8:30 AM ET that morning to review financial results and provide a corporate update focused on the clinical advancement of agenT-797, MiNK's off-the-shelf allogeneic iNKT cell therapy, in acute lung injury.

Related Symbols 1

I INKT INKT

Source: GlobeNewsWire

Visit Source

0 0 0

Comment

WSJ News Agency

4 days ago•WSJ

Stocks Medium Importance Neutral

U.K. Waves Through $81 Billion Paramount-Warner Bros. Deal

The deal still faces substantial legal challenges in the U.S., where state attorneys general have sued to block the purchase.

Related Symbols 1

P PGRE PGRE

Source: WSJ

Visit Source

0 0 0

Comment

PYMNTS News Agency

4 days ago•PYMNTS

Stocks Medium Importance Neutral

ThredUp Navigates K-Shaped Economy as Revenues Climb 17%

Online secondhand marketplace ThredUp is adjusting its marketing tactics while navigating a “K-shaped” economy. The company reported quarterly earnings Wednesday (Aug. 5) showing revenues of $90.8 million, up 17% from the same quarter last year.

Related Symbols 1

T TDUP TDUP

Source: PYMNTS

Visit Source

0 0 0

Comment

GlobeNewsWire News Agency

4 days ago•GlobeNewsWire

Stocks Medium Importance Neutral

AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

Initial agreement contemplates the purchase of up to 128 NVIDIA HGX B300 AI systems with an estimated aggregate hardware value of approximately $77 million based on current market pricing, subject to future purchase orders and customary conditions

Related Symbols 1

NVDA NVIDIA Corporation

Source: GlobeNewsWire

Visit Source

0 0 0

Comment

Seeking Alpha News Agency

4 days ago•Seeking Alpha

Stocks Medium Importance Neutral

Albemarle: Strong Q2 Earnings, But Not A Buy Yet

Albemarle Corporation delivered strong Q2 2026 results, beating revenue and EPS estimates and raising guidance in its Specialties division. ALB generated $638M in free cash flow, reduced capital expenditures by 15%, and improved its balance sheet with significant debt repayment. Lithium demand is set to multiply, driven by both electric vehicles and surging energy storage needs, supporting ALB's long-term growth outlook.

Related Symbols 1

A ALB ALB

Source: Seeking Alpha

Visit Source

Special Offer LiteFinance Start Trading

0 0 0

Comment

24/7 Wall Street News Agency

4 days ago•24/7 Wall Street

Stocks Medium Importance Neutral

What Prediction Markets Tell Us About 2 of America's Most At-Risk Brands

Prediction markets have become a real-time barometer for corporate distress, layering crowd-sourced probability on top of balance sheets that already tell the story.

Related Symbols 1

P PLUG PLUG

Source: 24/7 Wall Street

Visit Source

Special Offer LiteFinance Start Trading

0 0 0

Comment

GlobeNewsWire News Agency

4 days ago•GlobeNewsWire

Stocks Medium Importance Neutral

Freshworks Achieves FedRAMP® "In Process" Designation for Freshservice, Advancing AI-Powered Service Operations for the Public Sector

SAN MATEO, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) today announced that Freshservice, its AI-powered unified service operations platform, has achieved FedRAMP® ‘In-Process' status for Class C (Moderate) certification, signaling significant progress toward full authorization for U.S. federal government agencies. This designation marks a key milestone in Freshworks' plan to deliver modern service management software to federal agencies, and Freshservice is now listed on the FedRAMP Marketplace. Freshworks has engaged Coalfire, a leading provider of FedRAMP compliance assessments, to guide the authorization process.

Related Symbols 1

F FRSH FRSH

Source: GlobeNewsWire

Visit Source

0 0 0

Comment

PRNewsWire News Agency

4 days ago•PRNewsWire

Stocks Medium Importance Neutral

NREF Announces Second Quarter 2026 Results, Provides Third Quarter 2026 Guidance

DALLAS, Aug. 6, 2026 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended June 30, 2026. NREF reported net income attributable to common stockholders of $5.4 million, or $0.29 per diluted share1, for the three months ended June 30, 2026.

Related Symbols 1

N NREF NREF

Source: PRNewsWire

Visit Source

0 0 0

Comment

GlobeNewsWire News Agency

4 days ago•GlobeNewsWire

Stocks Medium Importance Neutral

RedCloud Signs Open Weights and American AI Leadership Letter Alongside Microsoft, NVIDIA and OpenAI

RedCloud joins Microsoft, NVIDIA, Meta, OpenAI and others in backing open-weight AI — allowing the Company to specialise advanced models on FMCG trading data inside its own infrastructure, and deliver market-level intelligence without customer data leaving that environment RedCloud joins Microsoft, NVIDIA, Meta, OpenAI and others in backing open-weight AI — allowing the Company to specialise advanced models on FMCG trading data inside its own infrastructure, and deliver market-level intelligence without customer data leaving that environment

Related Symbols 1

MSFT Microsoft Corporation

Source: GlobeNewsWire

Visit Source

0 0 0

Comment

GlobeNewsWire News Agency

4 days ago•GlobeNewsWire

Stocks Medium Importance Neutral

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

August 6, 2026 – 7:45 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company today announced that Avena Merger Sub Inc. (“Purchaser”), a wholly-owned subsidiary of argenx BV (“argenx”), has commenced a tender offer to purchase all of the issued and outstanding shares of Common Stock, par value $0.001 per share (the “Shares”), of Forte Biosciences, Inc. (“Forte”) (Nasdaq: FBRX), for $77.00 per Share, net to the seller in cash, without interest, subject to any applicable withholding taxes, and upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August 6, 2026, and the accompanying Letter of Transmittal (together, and with other related materials, as they may be amended or supplemented from time to time, the “Offer”). The Offer is being made pursuant to an Agreement and Plan of Merger, dated as of July 26, 2026, by and among Forte, argenx and Purchaser (the “Merger Agreement”).

Related Symbols 1

F FBRX FBRX

Source: GlobeNewsWire

Visit Source

Special Offer LiteFinance Start Trading

0 0 0

Comment

24/7 Wall Street News Agency

4 days ago•24/7 Wall Street

Stocks Medium Importance Neutral

Load Up On AMD Because Its High Beta Will Reward You Now

At $518.58, Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) looks compelling, and its punishing beta of 2.49 works in shareholders' favor at this stage of the AI capex cycle.

Related Symbols 1

A AMD AMD

Source: 24/7 Wall Street

Visit Source

0 0 0

Comment

WSJ News Agency

4 days ago•WSJ

Stocks Medium Importance Neutral

Warby Parker Swings to Profit on Tariff Refund

Warby Parker swung to a second-quarter profit as results were helped by a tariff refund, offsetting costs of the upcoming launch of its artificial-intelligence eyewear.

Related Symbols 1

W WRBY WRBY

Source: WSJ

Visit Source

0 0 0

Comment

Market News

User Menu